Positron Emission Tomography (PET) in Oncology
Since its introduction in the early nineties as a promising functional imaging technique in the management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has become a cornerstone in several oncologic procedures such as tumor staging and restaging, treatment efficacy assessment durin...
Main Authors: | Andrea Gallamini, Colette Zwarthoed, Anna Borra |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/6/4/1821 |
Similar Items
-
Positron Emission Tomography in Breast Cancer
by: Jose Luis Vercher-Conejero, et al.
Published: (2015-03-01) -
The Role of Positron Emission Tomography- Computed Tomography/Magnetic Resonance Imaging in Modern Medicine
by: Sina Houshmand, et al.
Published: (2014-09-01) -
Application of FDG-PET/CT in Radiation Oncology
by: Jun eLi, et al.
Published: (2013-04-01) -
False-positive 18-fluorodeoxyglucose positron emission tomography–computed tomography (FDG PET/CT) scans mimicking malignancies
by: Zehra Yasar, et al.
Published: (2015-02-01) -
Detection of Pacemaker Lead Infection by Fluorodeoxyglucose Positron Emission Tomography
by: Takashi Miura, MD, et al.
Published: (2006-01-01)